Increased IgE serum levels are unrelated to allergic and parasitic diseases in patients with juvenile systemic lupus erythematosus
Carregando...
Citações na Scopus
11
Tipo de produção
article
Data de publicação
2012
Título da Revista
ISSN da Revista
Título do Volume
Editora
HOSPITAL CLINICAS, UNIV SAO PAULO
Autores
Citação
CLINICS, v.67, n.11, p.1275-1280, 2012
Resumo
OBJECTIVE: The aim of this study was to assess the IgE serum levels in juvenile systemic lupus erythematosus patients and to evaluate possible associations with clinical and laboratory features, disease activity and tissue damage. METHODS: The IgE serum concentrations in 69 consecutive juvenile systemic lupus erythematosus patients were determined by nephelometry. IgG, IgM and IgA concentrations were measured by immunoturbidimetry. All patients were negative for intestinal parasites. Statistical analysis methods included the Mann-Whitney, chi-square and Fisher's exact tests, as well as the Spearman rank correlation coefficient. RESULTS: Increased IgE concentrations above 100 IU/mL were observed in 31/69 (45%) juvenile systemic lupus erythematosus patients. The mean IgE concentration was 442.0 +/- 163.4 IU/ml (range 3.5- 9936.0 IU/ml). Fifteen of the 69 patients had atopic disease, nine patients had severe sepsis and 56 patients presented with nephritis. The mean IgE level in 54 juvenile systemic lupus erythematosus patients without atopic manifestations was 271.6 +/- 699.5 IU/ml, and only nine of the 31 (29%) patients with high IgE levels had atopic disease. The IgE levels did not statistically differ with respect to the presence of atopic disease, severe sepsis, nephritis, disease activity, or tissue damage. Interestingly, IgE concentrations were inversely correlated with C4 levels ( r = -0.25, p = 0.03) and with the SLICC/ACR-DI score (r = -0.34, p = 0.005). The IgE concentration was also found to be directly correlated with IgA levels (r = 0.52, p = 0.03). CONCLUSIONS: The present study demonstrated for the first time that juvenile systemic lupus erythematosus patients have increased IgE serum levels. This increase in IgE levels was not related to allergic or parasitic diseases. Our results are in line with the hypothesis that high IgE levels can be considered a marker of immune dysregulation.
Palavras-chave
Juvenile Systemic Lupus Erythematosus, IgE, Intestinal Parasite, Allergic Disease
Referências
- Atta AM, 2010, INT ARCH ALLERGY IMM, V152, P401, DOI 10.1159/000288293
- Atta AM, 2004, BRAZ J MED BIOL RES, V37, P1497
- Barnes PJ, 2005, IMMUNOL ALLERGY CLIN, V25, P251
- Becker LC, 1973, HOPKINS MED J, V133, P38
- BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606
- CAMERON JS, 1994, PEDIATR NEPHROL, V8, P230
- Carneiro-Sampaio M, 2008, J CLIN IMMUNOL, V28, pS34, DOI 10.1007/s10875-008-9187-2
- DATI F, 1982, CLIN CHEM, V28, P1556
- EGIDO J, 1980, ANN RHEUM DIS, V39, P312, DOI 10.1136/ard.39.4.312
- ELKAYAM O, 1995, ALLERGY, V50, P94
- GEHA RS, 1992, J ALLERGY CLIN IMMUN, V90, P143, DOI 10.1016/0091-6749(92)90064-9
- Gladman DD, 1997, ARTHRITIS RHEUM-US, V40, P809, DOI 10.1002/art.1780400506
- Gladman DD, 2002, J RHEUMATOL, V29, P288
- GOLDMAN JA, 1976, ARTHRITIS RHEUM, V19, P669, DOI 10.1002/1529-0131(197607/08)19:4<669::AID-ART1780190403>3.0.CO;2-E
- Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2, DOI 10.1097/01.PCC.0000149131.72248.E6
- GRUBER BL, 1988, ARTHRITIS RHEUM, V31, P1000, DOI 10.1002/art.1780310810
- Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928
- LAURENT J, 1986, AM J NEPHROL, V6, P413, DOI 10.1159/000167202
- Liphaus BL, 2010, CLINICS, V65, P327, DOI 10.1590/S1807-59322010000300014
- Liston A, 2008, NAT REV IMMUNOL, V8, P545, DOI 10.1038/nri2336
- Mancini I, 1996, J Pediatr (Rio J), V72, P98
- MCPHAUL JJ, 1974, KIDNEY INT, V5, P292, DOI 10.1038/ki.1974.39
- MIKECZ K, 1985, ACTA MED HUNG, V42, P59
- Mok CC, 2003, J CLIN PATHOL, V56, P481, DOI 10.1136/jcp.56.7.481
- Morton S, 1998, ANN RHEUM DIS, V57, P660, DOI 10.1136/ard.57.11.660
- PETRI M, 1992, J RHEUMATOL, V19, P265
- REBHUN J, 1983, ANN ALLERGY, V50, P34
- Ring GH, 1999, SEMIN NEPHROL, V19, P25
- ROBERTSON MR, 1976, NEPHRON, V16, P256, DOI 10.1159/000180610
- ROMAGNANI S, 1994, ANNU REV IMMUNOL, V12, P227, DOI 10.1146/annurev.immunol.12.1.227
- Rosner B., 2000, FUNDAMENTALS BIOSTAT
- SASAI K, 1995, ALLERGY, V50, P370, DOI 10.1111/j.1398-9995.1995.tb01163.x
- Sekigawa I, 2002, LUPUS, V11, P426, DOI 10.1191/0961203302lu221oa
- Sekigawa I, 2003, CLIN EXP RHEUMATOL, V21, P117
- Sekigawa I, 2003, CLIN EXP RHEUMATOL, V21, P683
- Sekigawa I, 2004, CLIN EXP RHEUMATOL, V22, P384
- SEQUEIRA JF, 1993, LUPUS, V2, P187, DOI 10.1177/096120339300200311
- Shahar E, 1997, ISRAEL J MED SCI, V33, P147
- Spalding SM, 2000, VER ASS MED BARSIL, V46, P93
- TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101
- TUMA SN, 1981, AM J NEPHROL, V1, P31, DOI 10.1159/000166485
- WITTIG HJ, 1980, J ALLERGY CLIN IMMUN, V66, P305, DOI 10.1016/0091-6749(80)90026-3
- Wozniacka A, 2003, MEDIAT INFLAMM, V12, P95, DOI 10.1080/0962935031000097709